New resource for selecting best treatment path for young children with cancerous tumors published by NCCN

March 8, 2024
New NCCN Guidelines for Neuroblastoma address the importance and impact of risk stratification for treating one of the more common types of pediatric solid tumors; includes vanguard treatment recommendations involving multimodality treatment for high-risk disease.

The National Comprehensive Cancer Network (NCCN) published a set of treatment recommendations pertaining to neuroblastoma.

There are now 87 different NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), covering nearly every type of cancer, plus screening, prevention, and supportive care. The NCCN Guidelines for Neuroblastoma are the 6th to focus specifically on treating pediatric cancer.     

NCCN also publishes NCCN Guidelines for Adolescent and Young Adult Oncology, which provide treatment advice geared toward younger populations across all cancer types. There are separate NCCN Guidelines for Survivorship that include additional information on mitigating the long-term impact of treatment.

NCCN release on Newswise

Photo 88130778 © Nataliia Mysik |
Photo 186155390 © Noipornpan |
Photo 171358238 © Nataliia Mysik |
Photo 84222773 © 7active Studio |
Photo 43618677 © Anupong Thiprot |